1. Home
  2. NKGN vs INLX Comparison

NKGN vs INLX Comparison

Compare NKGN & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKGN
  • INLX
  • Stock Information
  • Founded
  • NKGN 2017
  • INLX 1996
  • Country
  • NKGN United States
  • INLX United States
  • Employees
  • NKGN N/A
  • INLX N/A
  • Industry
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • INLX EDP Services
  • Sector
  • NKGN Health Care
  • INLX Technology
  • Exchange
  • NKGN Nasdaq
  • INLX Nasdaq
  • Market Cap
  • NKGN 8.1M
  • INLX 53.8M
  • IPO Year
  • NKGN N/A
  • INLX N/A
  • Fundamental
  • Price
  • NKGN $0.70
  • INLX $12.75
  • Analyst Decision
  • NKGN
  • INLX
  • Analyst Count
  • NKGN 0
  • INLX 0
  • Target Price
  • NKGN N/A
  • INLX N/A
  • AVG Volume (30 Days)
  • NKGN 872.6K
  • INLX 14.0K
  • Earning Date
  • NKGN 11-12-2024
  • INLX 11-12-2024
  • Dividend Yield
  • NKGN N/A
  • INLX N/A
  • EPS Growth
  • NKGN N/A
  • INLX N/A
  • EPS
  • NKGN N/A
  • INLX 0.04
  • Revenue
  • NKGN N/A
  • INLX $17,589,795.00
  • Revenue This Year
  • NKGN N/A
  • INLX $9.27
  • Revenue Next Year
  • NKGN N/A
  • INLX $8.10
  • P/E Ratio
  • NKGN N/A
  • INLX $331.35
  • Revenue Growth
  • NKGN N/A
  • INLX 7.63
  • 52 Week Low
  • NKGN $0.20
  • INLX $3.76
  • 52 Week High
  • NKGN $5.10
  • INLX $14.98
  • Technical
  • Relative Strength Index (RSI)
  • NKGN 66.41
  • INLX 58.02
  • Support Level
  • NKGN $0.20
  • INLX $12.50
  • Resistance Level
  • NKGN $0.30
  • INLX $13.12
  • Average True Range (ATR)
  • NKGN 0.08
  • INLX 0.90
  • MACD
  • NKGN 0.03
  • INLX -0.11
  • Stochastic Oscillator
  • NKGN 74.55
  • INLX 43.69

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.

Share on Social Networks: